CDK4 Antikörper (AA 6-295)
Kurzübersicht für CDK4 Antikörper (AA 6-295) (ABIN7615506)
Target
Alle CDK4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 6-295
-
Verwendungszweck
- Cyclin Dependent Kinase 4 (CDK4) Polyclonal Antibody
-
Sequenz
- Tyr6~Leu295
-
Produktmerkmale
- The Cyclin Dependent Kinase 4 (CDK4) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC.
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CDK4 (Cyclin-Dependent Kinase 4 (CDK4))
-
Andere Bezeichnung
- CDK4
-
Gen-ID
- 1019
-
UniProt
- P11802
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases, Regulation of Cell Size
Target
-